In this episode, we're joined byReed Shafer-Ray to talk about moral entrepreneurship, his new effort called Mountaintop, how to reshape the culture of American elites and a whole lot more.  Reed is a Harvard grad who cofounded Lead for America. 

In this episode, we're joined by Resident Contrarian to discuss being poor in America, the state of Christianity, social conservatism, and a whole lot more.  Resident blogs at: https://www.residentcontrarian.com/

In this episode, I'm joined by Zohar Atkins to discuss the future of Liberalism, hierarchy, AI, religion and a whole lot more. 

In this episode, we are joined by Rohit Krishanan to talk about EA, the value of management consultants, the common traits of companies that last a long time, and where all of the Beethoven's went.  Rohit blogs at https://www.strangeloopcanon.com/ 

I recorded an episode with Marshall Kosloff about theories of change and progress, what outsiders get right and wrong about the American political system, why politicians should wear suits, and a whole lot more. This episode was cohosted by Lars Doucet. You can find Marshall's podcast at https://podcasts.apple.com/us/podcast/the-realignment/id1474687988

In this episode, I'm joined by Jeffrey Ladish to discuss AI alignment, the possibility of abundance and how information security matters for alignment. Jeffrey blogs at https://jeffreyladish.com/

In this episode, we're joined by Lars Doucet to discuss his new book, Land Is A Big Deal. You can buy it here: https://www.shacksimplepress.com/product-page/land-is-a-big-deal

In this episode, we're joined by urban economist Stephen Hoskins to discuss the relationship between zoning and land value. This episode was cohosted by Lars Doucet.  https://progressandpoverty.substack.com/p/land-and-the-liberty-to-build-on

In this episode we're joined by early stage investor Minn Kim to talk about Industrial Progress, Immigration and the American Dream. We also cover the future of frontier tech, and how to enable more successful hard tech companies through better policy. 

In this episode we are joined by Trevor Klee. Trevor is the founder of Highway Pharmaceuticals is a biotech startup creating drugs for autoimmune diseases. Right now, they're running a pilot trial of our drug in feline stomatitis.    Feline stomatitis is a serious autoimmune disease that affects 1 million cats per year in the US. The only treatment for it currently is a $1k+ surgery. By the end of the trial, we expect to have evidence that our drug can safely and effectively suppress the feline immune system. This positions our drug to become the only alternative to an expensive and traumatizing surgery.   Trevor is currently raising funds to cover the rest of the costs of the trial, as well as position us for our next milestones, which you can check out here: https://wefunder.com/highway.pharmaceuticals/